Go to Contents Go to Navigation

(4th LD) Daily infections over 4,000 for 2nd day; imported cases hit record high

All News 19:48 January 13, 2022

(ATTN: UPDATES with latest figures in paras 10-11)

SEOUL, Jan. 13 (Yonhap) -- South Korea said Thursday it will ban all entrants from using ordinary public transportation to try to stem the inflow of the omicron variant from overseas as the number of imported cases reached an all-time high.

The Korea Disease Control and Prevention Agency (KDCA) said all entrants must use their private vehicles, or officially designated infection-proof taxis, buses or trains.

They will also be required to present negative test results issued within 48 hours before their departure for South Korea, rather than the current 72 hours.

The strengthened measures, which will go into effect on Jan. 20, come as the number of imported cases has surged in recent days to hit an all-time high of 391 on Thursday.

More than 80 percent of the total imported cases reported last week were found to have been infected with the omicron variant on average, according to the KDCA.

A person moves to a COVID-19 testing station set up at Incheon International Airport, west of Seoul, upon arrival in South Korea on Jan. 13, 2022. (Yonhap)

South Korea reported 4,167 new COVID-19 infections on Thursday, including 3,776 local infections, raising the total caseload to 679,030, according to the KDCA.

The virus situation has showed signs of slowing down in recent weeks thanks to the tightened antivirus restrictions and the active campaign for booster shots, but the health authorities have remained vigilant due to the fast spread of the omicron variant.

"The omicron variant is expected to become the dominant COVID-19 strain in South Korea within one to two weeks," health ministry official Son Young-rae said in a briefing.

About 12.5 percent of the country's locally transmitted cases reported last week were found to have been caused by the omicron variant, according to the KDCA.

As of 6 p.m., the country had added 3,015 new virus cases, up 246 from the same time the previous day and 489 from a week before, according to health authorities and local governments. The greater Seoul area accounted for 63.7 percent of the infections.

Daily cases are counted until midnight and announced the following morning.

In this file photo, Vietnamese workers board a bus upon arrival at Incheon International Airport, west of Seoul, to head for facilities near the airport for isolation on Dec. 3, 2021, when the South Korean government imposed a 10-day quarantine on all entrants from abroad amid mounting concerns over the additional influx of the omicron coronavirus variant. (Yonhap)

The KDCA vowed to continue the so-called flight circuit breaker scheme, which grounds international flights for one week in case they report more than three confirmed cases among their non-Korean passengers.

Around over the past month, the government activated the measure 24 times for 16 flight routes linking South Korea to 11 countries, including the U.S. and Vietnam.

The government also plans to secure more accommodations for entrants' mandatory self-isolation, the KDCA said.

"Rather than seeking an entry ban on entrants from specific nations, it is more crucial to reduce exemptions from self-isolation to a minimum level," Son said.

On Thursday, South Korea reported 44 more COVID-19 deaths, raising the death toll to 6,210, according to the KDCA. The fatality rate came to 0.91 percent.

The number of critically ill COVID-19 patients stood at 701, staying below 800 for the fourth straight day, it said.

Workers move crates carrying U.S. drug giant Pfizer Inc.'s Paxlovid antiviral COVID-19 treatment pills at Incheon International Airport, west of Seoul, on Jan. 13, 2022, as the first batch for 21,000 people arrived in South Korea. The oral pills will begin being administered the following day to patients with a compromised immune system and those aged over 65, with the second batch for 10,000 people to be shipped by the end of this month, according to health authorities. (Pool photo) (Yonhap)

Earlier in the day, the first batch of U.S. drug giant Pfizer Inc.'s Paxlovid antiviral COVID-19 treatment pills arrived in South Korea.

The oral pills for 21,000 people will begin being administered Friday to patients with a compromised immune system and those aged over 65, with the second batch for 10,000 people to be shipped by the end of this month, the KDCA said.

South Korea has secured Pfizer's medication for 762,000 people, as well as oral pills made by U.S. drugmaker's MSD for 242,000 people.

As of Thursday, 43.3 million people, or 84.4 percent of the country's 52 million population, have been fully vaccinated, and 22.1 million, or 43.1 percent, have received booster shots, the health authorities said.

On Wednesday, South Korea also authorized the use of U.S.-based biotechnology company Novavax Inc.'s COVID-19 vaccine, which is expected to be used as early as next month. The authorities said this "classic" type of vaccine could encourage more unvaccinated people to consider getting a shot and further boost the country's overall vaccination rate.

The government plans to announce its decision Friday on whether to extend the current social distancing rules, which went into effect in mid-December in the wake of a drastic surge in infections and will expire Sunday.

Some have raised the possibility of the rules being relaxed, but officials say the current curbs are likely to be extended for at least two weeks, citing concerns over an uptick around the Lunar New Year holiday later this month.

Of the locally transmitted cases, 66.9 percent were from the metropolitan region. Seoul reported 868, and the surrounding Gyeonggi Province and the city of Incheon, west of Seoul, added 1,444 and 224 new cases, respectively.

A health worker prepares to conduct COVID-19 tests at a makeshift testing station in Seoul on Jan. 12, 2022, amid a cold wave.


Send Feedback
How can we improve?
Thanks for your feedback!